First Page | Document Content | |
---|---|---|
Macrolides Kidney cancer Neuroendocrine tumor Pediatric cancers Sunitinib Renal cell carcinoma Carcinoid Everolimus End point of clinical trials Medicine Oncology Immunosuppressants | Microsoft Word - Everolimus Briefing Document.docAdd to Reading ListSource URL: www.fda.govDownload Document from Source WebsiteFile Size: 541,22 KBShare Document on Facebook |